This is a preview of subscription content, log in via an institution to check access.
Notes
M915601, M915602
Reference
FDA. Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity. Internet Document : 11 Jun 2021. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/viona-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hcl-extended-release-tablets
Rights and permissions
About this article
Cite this article
US recall of metformin hydrochloride extended-release tablets. Reactions Weekly 1861, 7 (2021). https://doi.org/10.1007/s40278-021-97807-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97807-1